Skip to content

Telemedicine for PrEP Throughout Mississippi

Telemedicine for PrEP Throughout Mississippi

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03840382
Acronym
Tele-PrEP
Enrollment
74
Registered
2019-02-15
Start date
2019-12-19
Completion date
2022-05-04
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Brief summary

This study will develop and test a program to deliver PrEP care in underserved communities in Mississippi (MS) through telemedicine, distance-based, clinical care delivered in local community based organizations (CBOs). The intervention will be developed in collaboration with medical specialists at the University of Mississippi Medical Center (UMMC) and local CBO stakeholders (providers, administrators and patients). Approximately 75 individuals will be recruited from CBOs in MS. Participants will be able to receive PrEP counseling in the CBO and PrEP care via telemedicine from a PrEP specialist at UMMC. Participants will complete three assessments in the six months after enrolling. Our study will provide a wealth of information about PrEP-related outcomes and HIV testing among MS residents living in underserved communities. If successful, this program will be able to be disseminated to other CBOs in the South.

Detailed description

Uptake of PrEP in the southern United States has been slow, especially in areas distant from academic medical centers that provide PrEP care. Despite underserved populations in the South having alarmingly high rates of HIV, a large percentage of at-risk individuals are not engaged in PrEP care due to limited access to academic medical centers. Mississippi (MS), the site of this proposed project, has the seventh highest incidence of HIV of any state and CBOs that provide HIV/STI testing outside of urban areas report that very few of their at-risk individuals use PrEP. Unfortunately, physicians outside of academic centers are often reluctant to prescribe PrEP because they lack the expertise, training, and the support necessary to provide comprehensive HIV prevention care. Those are at-risk do not seek PrEP from academic centers because of stigma, travel burdens, and financial concerns. To overcome these barriers, this project will develop and pilot test a program to deliver PrEP care in underserved remote communities in MS through telemedicine clinical care delivered in local CBOs. Telemedicine will allow specialists to provide care at a distance and while simultaneously enhancing the capacity of local CBOs to provide quality HIV testing and counseling, PrEP treatment, and linkage to HIV care if needed. It will allow patients to receive the highest level of medical care from trusted CBOs within their local communities. It will also enhance the CBO's mission by allowing it to provide a new, high-quality medical service.

Interventions

BEHAVIORALTele-PrEP Intervention

Telemedicine conferences with PrEP-specialists

Sponsors

University of Mississippi Medical Center
CollaboratorOTHER
Rhode Island Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years old or older * Presented at a collaborating CBO for HIV testing during trial months * PrEP eligible based on HIV Risk Checklist * Able to read and speak English * Able to give meaningful consent as determined by research staff * No known HIV infection

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With 0-2 PrEP Refills at 6 Months (Electronic Medical Record)Assessed at 6 monthsNumber of Participants With 0-2 PrEP Refills in past 3 months (extracted from electronic medical record at 6-month follow-up).
Number of Participants Who Received a PrEP Medication Prescription at 6 Months (Electronic Medical Record Extraction)Assessed at 6 monthsNumber of participants who received a PrEP medication prescription in past 3 months, extracted from patient's electronic medical record at 6-month follow-up.
Adherence to PrEP (Self-report)Assessed at 3 months and 6 monthsSelf-reported number of days a PrEP dose was missed in the past 30 days. Ranging from 0 to 30.
Number of Participants With 0-2 PrEP Refills at 3 Months (Electronic Medical Record )Assessed at 3 monthsNumber of participants with 0-2 PrEP medication refills in past 3 months (extracted from electronic medical record at 3-month follow-up).
Number of Participants Who Attended One or More PrEP Telemedicine Appointments at 3 Months Post-intervention (Electronic Medical Record Extraction)Assessed at 3 monthsNumber of participants who attended one or more PrEP telemedicine appointments with a UMMC PrEP specialist, in the past 3 months, extracted from patient's electronic medical record at 3 months post-intervention.
Number of Participants Who Attended One or More PrEP Telemedicine Appointments at 6 Months Post-intervention (Electronic Medical Record Extraction)Assessed at 6 monthsNumber of participants who attended one or more PrEP telemedicine appointments with a UMMC PrEP specialist, in the past 3 months, extracted from patient's electronic medical record at 6 months post-intervention.
Number of Participants Who Received a PrEP Medication Prescription at 3 Months (Electronic Medical Record Extraction)Assessed at 3 monthsNumber of participants who received a PrEP medication prescription in past 3 months, extracted from patient's electronic medical record at 3-month follow-up.

Secondary

MeasureTime frameDescription
Motivational Readiness for PrEP and PrEP-related CareAssessed at 3 months and 6 monthsThis measure was a subscale adapted from The LifeWindows Information Motivation Behavioral Skills ART Adherence Questionnaire (LW-IMB-AAQ), 2006. The motivational readiness to engage in PrEP care subscale consisted of eight items with 4-point Likert responses. The possible score range for this subscale is 8 to 32, with higher scores indicating higher motivation to engage in PrEP care.
Patient Acceptability Score Regarding the Use of Telemedicine for PrEP Care (CSQ-8)Assessed at 3 months and 6 monthsPatients' perspective on the acceptability of using telemedicine for PrEP care was assessed with a modified version of the Client Satisfaction Questionnaire (CSQ-8). This measure was only given to participants who attended a PrEP-related telemedicine appointment. Scores for this measure could range from 2 to 8, with higher scores indicating greater satisfaction.
PrEP KnowledgeAssessed at 3 months and 6 monthsThis 5-item measure was used to assess knowledge (true/false/don't know) based on facts from the CDC and the San Francisco AIDS Foundation websites concerning PrEP. Scores for the measure could range from 0 to 5 with higher scores indicating greater PrEP knowledge.

Countries

United States

Participant flow

Participants by arm

ArmCount
Tele-PrEP Intervention
The telemedicine intervention will allow participants to discuss HIV prevention and PrEP with PrEP specialists at an academic medical center via videoconference from their local community based organization (CBO). During the intervention, participants will gain information related to HIV and PrEP, view a video to improve motivation for engagement in PrEP related care, and receive resources to address barriers to care. Tele-PrEP Intervention: Telemedicine conferences with PrEP-specialists
63
Total63

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up11

Baseline characteristics

CharacteristicTele-PrEP Intervention
Age, Continuous30.3 years
STANDARD_DEVIATION 9.1
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
60 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Motivational readiness for PrEP and PrEP-related care25.07 score on a scale
STANDARD_DEVIATION 4.37
PrEP knowledge2.63 score on a scale
STANDARD_DEVIATION 1.72
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
51 Participants
Race (NIH/OMB)
More than one race
1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
9 Participants
Sex: Female, Male
Female
31 Participants
Sex: Female, Male
Male
32 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 63
other
Total, other adverse events
0 / 63
serious
Total, serious adverse events
0 / 63

Outcome results

Primary

Adherence to PrEP (Self-report)

Self-reported number of days a PrEP dose was missed in the past 30 days. Ranging from 0 to 30.

Time frame: Assessed at 3 months and 6 months

Population: Only participants who self-reported current PrEP use were included in these analyses.

ArmMeasureGroupValue (MEAN)Dispersion
Tele-PrEP InterventionAdherence to PrEP (Self-report)Missed Doses at 3-Months2.07 missed PrEP dosesStandard Deviation 3.03
Tele-PrEP InterventionAdherence to PrEP (Self-report)Missed Doses at 6-Months18.75 missed PrEP dosesStandard Deviation 13.5
Primary

Number of Participants Who Attended One or More PrEP Telemedicine Appointments at 3 Months Post-intervention (Electronic Medical Record Extraction)

Number of participants who attended one or more PrEP telemedicine appointments with a UMMC PrEP specialist, in the past 3 months, extracted from patient's electronic medical record at 3 months post-intervention.

Time frame: Assessed at 3 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Tele-PrEP InterventionNumber of Participants Who Attended One or More PrEP Telemedicine Appointments at 3 Months Post-intervention (Electronic Medical Record Extraction)8 Participants
Primary

Number of Participants Who Attended One or More PrEP Telemedicine Appointments at 6 Months Post-intervention (Electronic Medical Record Extraction)

Number of participants who attended one or more PrEP telemedicine appointments with a UMMC PrEP specialist, in the past 3 months, extracted from patient's electronic medical record at 6 months post-intervention.

Time frame: Assessed at 6 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Tele-PrEP InterventionNumber of Participants Who Attended One or More PrEP Telemedicine Appointments at 6 Months Post-intervention (Electronic Medical Record Extraction)2 Participants
Primary

Number of Participants Who Received a PrEP Medication Prescription at 3 Months (Electronic Medical Record Extraction)

Number of participants who received a PrEP medication prescription in past 3 months, extracted from patient's electronic medical record at 3-month follow-up.

Time frame: Assessed at 3 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Tele-PrEP InterventionNumber of Participants Who Received a PrEP Medication Prescription at 3 Months (Electronic Medical Record Extraction)22 Participants
Primary

Number of Participants Who Received a PrEP Medication Prescription at 6 Months (Electronic Medical Record Extraction)

Number of participants who received a PrEP medication prescription in past 3 months, extracted from patient's electronic medical record at 6-month follow-up.

Time frame: Assessed at 6 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Tele-PrEP InterventionNumber of Participants Who Received a PrEP Medication Prescription at 6 Months (Electronic Medical Record Extraction)17 Participants
Primary

Number of Participants With 0-2 PrEP Refills at 3 Months (Electronic Medical Record )

Number of participants with 0-2 PrEP medication refills in past 3 months (extracted from electronic medical record at 3-month follow-up).

Time frame: Assessed at 3 months

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Tele-PrEP InterventionNumber of Participants With 0-2 PrEP Refills at 3 Months (Electronic Medical Record )0 Refills43 Participants
Tele-PrEP InterventionNumber of Participants With 0-2 PrEP Refills at 3 Months (Electronic Medical Record )1 Refill11 Participants
Tele-PrEP InterventionNumber of Participants With 0-2 PrEP Refills at 3 Months (Electronic Medical Record )2 Refills9 Participants
Primary

Number of Participants With 0-2 PrEP Refills at 6 Months (Electronic Medical Record)

Number of Participants With 0-2 PrEP Refills in past 3 months (extracted from electronic medical record at 6-month follow-up).

Time frame: Assessed at 6 months

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Tele-PrEP InterventionNumber of Participants With 0-2 PrEP Refills at 6 Months (Electronic Medical Record)0 Refills46 Participants
Tele-PrEP InterventionNumber of Participants With 0-2 PrEP Refills at 6 Months (Electronic Medical Record)1 Refill12 Participants
Tele-PrEP InterventionNumber of Participants With 0-2 PrEP Refills at 6 Months (Electronic Medical Record)2 Refills5 Participants
Secondary

Motivational Readiness for PrEP and PrEP-related Care

This measure was a subscale adapted from The LifeWindows Information Motivation Behavioral Skills ART Adherence Questionnaire (LW-IMB-AAQ), 2006. The motivational readiness to engage in PrEP care subscale consisted of eight items with 4-point Likert responses. The possible score range for this subscale is 8 to 32, with higher scores indicating higher motivation to engage in PrEP care.

Time frame: Assessed at 3 months and 6 months

Population: Only those who completed 80% of the scale or more are included in the analyses. This is why only 57 and 54 participants were included in the 3-month and 6-month analysis, respectively.

ArmMeasureGroupValue (MEAN)Dispersion
Tele-PrEP InterventionMotivational Readiness for PrEP and PrEP-related CareScore at 3-Months25.95 score on a scaleStandard Deviation 4.69
Tele-PrEP InterventionMotivational Readiness for PrEP and PrEP-related CareScore at 6-Months26.50 score on a scaleStandard Deviation 4.11
Secondary

Patient Acceptability Score Regarding the Use of Telemedicine for PrEP Care (CSQ-8)

Patients' perspective on the acceptability of using telemedicine for PrEP care was assessed with a modified version of the Client Satisfaction Questionnaire (CSQ-8). This measure was only given to participants who attended a PrEP-related telemedicine appointment. Scores for this measure could range from 2 to 8, with higher scores indicating greater satisfaction.

Time frame: Assessed at 3 months and 6 months

Population: Only those who attended a telemedicine for PrEP appointment and completed this measure on the survey were included in the analyses. By 3-month follow-up, 11 of 63 participants used telemedicine for PrEP care. By 6-month follow-up, 1 additional participant used telemedicine for PrEP care. This explains why the overall number of participants analyzed for this measure was 12, as opposed to 63.

ArmMeasureGroupValue (MEAN)Dispersion
Tele-PrEP InterventionPatient Acceptability Score Regarding the Use of Telemedicine for PrEP Care (CSQ-8)Score at 3-Months7.27 score on a scaleStandard Deviation 1.27
Tele-PrEP InterventionPatient Acceptability Score Regarding the Use of Telemedicine for PrEP Care (CSQ-8)Score at 6-Months7.50 score on a scaleStandard Deviation 1
Secondary

PrEP Knowledge

This 5-item measure was used to assess knowledge (true/false/don't know) based on facts from the CDC and the San Francisco AIDS Foundation websites concerning PrEP. Scores for the measure could range from 0 to 5 with higher scores indicating greater PrEP knowledge.

Time frame: Assessed at 3 months and 6 months

Population: Only those who completed 80% of the scale or more are included in the analyses. This is why only 57 and 54 participants were included in the 3-month and 6-month analysis, respectively.

ArmMeasureGroupValue (MEAN)Dispersion
Tele-PrEP InterventionPrEP KnowledgeScore at 3-months2.89 score on a scaleStandard Deviation 1.84
Tele-PrEP InterventionPrEP KnowledgeScore at 6-months2.93 score on a scaleStandard Deviation 1.64

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026